Education

2019 - PhD, Cell and Molecular Biosciences, Newcastle University (UK)

2014 - MSc, Genetics and Molecular Biology, Sapienza University (Italy)

2012 - BSc, Biological Sciences, Sapienza University (Italy)

Research Experience

Postdoctoral Research Associate, Newcastle University, Newcastle upon Tyne, United Kingdom, February 2020 - present

Postdoctoral Research Associate, Newcastle University, Newcastle upon Tyne, United Kingdom, July 2019 - December 2019

PhD student, Newcastle University, Newcastle upon Tyne, United Kingdom, March 2016 - June 2019

Research Assistant, Institut Curie, Paris, France, October 2014 - February 2016

Postgraduate student, Sapienza University, Rome, Italy, September 2012 - September 2014

Undergraduate student, Sapienza University, Rome, Italy, April 2012 - July 2012

Grants and awards

JGW Patterson Foundation Research Grant, May 2020 - Co-awardee

Newcastle University Research Travel Fund, February 2019

Post-submission PhD Scholarship, February 2019

Newcastle University PhD Studentship, September 2015 

CURRENT RESEARCH INTERESTS

Control of 3'-end formation in human breast cancer cells

Proper maturation of the 3' terminus of messenger RNAs (mRNAs) is essential to ensure functional gene expression. Most eukaryotes employ alternative polyadenylation (APA) to increase the number of RNA isoforms transcribed from one gene, thus allowing not only production of different proteins but also tissue-specific diversification of the protein function. However, aberrant APA leads to disruption of gene expression with severe consequences on genome stability, and can cause human disease and cancer. I am studying the mechanisms regulated by RNA binding proteins and chromatin modifications that prevent aberrant APA in breast cancer cells, which can help identify possible therapeutic targets for breast cancer treatment/prevention.

Funder: JGW Patternson Foundation

Regulation of transcriptional pausing by RNA binding proteins in breast cancer cells

Transcription across most human genes is generally paused near the start, both to allow quality control of the newly synthesised RNA and to regulate transcription levels. Disruption of this pathway has been linked to human disease and cancer. Several protein factors with a known role in cancer biology have been identified as regulators of transcription pausing (including c-myc). My research is focussing on characterising a possible role for oncogenic RNA binding proteins in this process, and understand their contribution to cancer progression and metastasis.

Funder: JGW Patternson Foundation (co-awardee)

PREVIOUS RESEARCH INTEREST

Chromatin regulation of transcription in the budding yeast Saccharomyces cerevisiae

During my PhD under the supervision of Dr Manolis Papamichos-Chronakis I described a mechanism of RNA quality control through premature transcription termination that depends on the chromatin remodeller INO80. A preprint of this study is currently deposited on Biorxiv (https://doi.org/10.1101/2020.03.02.973685).

Funder: Newcastle University

• Luzzi S, Hysenaj G, Siachisumo C, Cheung K, Gazzara M, James K, Dalgliesh C, Kheirollahi Chadegani M, Ehrmann I, Smith GR, Cockell SJ, Munkley J, Barash Y, Elliott DJ. RBMX enables productive RNA processing of ultra-long exons important for genome stability. bioRxiv 2020. Submitted.
• Luzzi S, Szachnowski U, Greener S, Gautier C, Han KH, Darke J, Piccinno R, Lafon A, Pugh BF, Morillon A, Papamichos-Chronakis M. The INO80 remodeler couples premature termination of mRNA synthesis with transcription elongation. bioRxiv 2020.